Tirzepatide is an advanced synthetic peptide studied for its dual activity at the glucose-dependent insulinotropic polypeptide receptor, known as GIP, and the glucagon-like peptide-1 receptor, known as GLP-1.<\/p>\n
Its distinctive dual-receptor profile makes Tirzepatide particularly relevant for laboratory research involving incretin signalling, receptor pharmacology, metabolic pathways and long-acting peptide development.<\/p>\n
Tirzepatide is a modified 39-amino-acid peptide based on the natural GIP sequence. Its molecular structure contains a C20 fatty-diacid component that promotes albumin binding and supports an extended molecular profile.<\/p>\n
Tirzepatide is a synthetic peptide engineered to interact with both GIP and GLP-1 receptors.<\/p>\n
GIP and GLP-1 belong to the incretin hormone family and are widely studied for their involvement in nutrient-responsive signalling, pancreatic cell activity, glucose-dependent pathways and communication between the digestive system, pancreas and central nervous system.<\/p>\n
Unlike compounds that interact exclusively with the GLP-1 receptor, Tirzepatide combines activity at two incretin-related receptor systems. This makes it an important reference compound for researchers comparing single-receptor and dual-receptor signalling.<\/p>\n
The dual GIP and GLP-1 receptor profile of Tirzepatide allows researchers to study how two related signalling pathways may interact within the same experimental model.<\/p>\n
Relevant areas of laboratory research include:<\/p>\n
Tirzepatide is based on the native GIP peptide sequence and contains several structural modifications designed to improve its molecular stability and duration.<\/p>\n
A C20 fatty-diacid component supports reversible albumin binding. Albumin-binding technology is an important research area in modern peptide development because it can reduce rapid molecular clearance and extend the period during which a peptide remains available for analysis.<\/p>\n
This specialised structure makes Tirzepatide relevant for research involving:<\/p>\n
Tirzepatid kann in kontrollierten Laborumgebungen untersucht werden, die Folgendes umfassen:<\/p>\n
Forscher k\u00f6nnen die Aktivierung und die nachgeschaltete Signal\u00fcbertragung von GIP- und GLP-1-Rezeptoren in zellul\u00e4ren oder biochemischen Modellen vergleichen.<\/p>\n
Tirzepatid ist relevant f\u00fcr Studien, die untersuchen, wie Inkretin-verwandte Rezeptorsysteme zur metabolischen Kommunikation und zur n\u00e4hrstoffabh\u00e4ngigen Signalgebung beitragen.<\/p>\n
Laboruntersuchungen k\u00f6nnen Rezeptorwege untersuchen, die mit der Signal\u00fcbertragung in der Bauchspeicheldr\u00fcse, glukoseabh\u00e4ngigen zellul\u00e4ren Reaktionen und Wechselwirkungen zwischen Inkretinhormonen in Zusammenhang stehen.<\/p>\n
GIP- und GLP-1-Rezeptoren werden im Hinblick auf die Kommunikation zwischen peripheren Stoffwechselsignalen und Regionen des zentralen Nervensystems untersucht, die an der Energiebilanz und der appetitbezogenen Signalgebung beteiligt sind.<\/p>\n
Aufgrund seiner lipidierten Struktur eignet sich Tirzepatid f\u00fcr die Forschung zur Albuminbindung, zur Peptidstabilit\u00e4t und zur Entwicklung von Molek\u00fclen mit verl\u00e4ngerter Wirkdauer.<\/p>\n
Forscher k\u00f6nnten Tirzepatid mit nativem GIP, nativem GLP-1, selektiven GLP-1-Rezeptoragonisten oder anderen Multi-Rezeptor-Peptidverbindungen vergleichen.<\/p>\n
| Produktmerkmale<\/th>\n | Information<\/th>\n<\/tr>\n<\/thead>\n |
|---|---|
| Produktname<\/td>\n | Tirzepatide<\/td>\n<\/tr>\n |
| Forschungsbezeichnung<\/td>\n | Dualer GIP- und GLP-1-Rezeptoragonist<\/td>\n<\/tr>\n |
| Produktkategorie<\/td>\n | Synthetisches Forschungspeptid<\/td>\n<\/tr>\n |
| Peptidstruktur<\/td>\n | Modifiziertes 39-Aminos\u00e4ure-Peptid<\/td>\n<\/tr>\n |
| Referenzsequenz<\/td>\n | Basierend auf der nat\u00fcrlichen GIP-Sequenz<\/td>\n<\/tr>\n |
| Molekulare Modifikation<\/td>\n | Lipidierte Struktur mit einer C20-Fetts\u00e4ure<\/td>\n<\/tr>\n |
| Prim\u00e4re Forschungsziele<\/td>\n | GIP- und GLP-1-Rezeptoren<\/td>\n<\/tr>\n |
| Bilden<\/td>\n | Lyophilisiertes Pulver<\/td>\n<\/tr>\n |
| Pr\u00e4sentation<\/td>\n | Versiegeltes Forschungsfl\u00e4schchen<\/td>\n<\/tr>\n |
| Dokumentation<\/td>\n | chargenspezifische analytische Dokumentation<\/td>\n<\/tr>\n |
| Verpackung<\/td>\n | Sichere und diskrete Verpackung<\/td>\n<\/tr>\n |
| Zweck der Anwendung<\/td>\n | Wissenschaftliche und Laborforschung<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\nLyophilisiertes Forschungsformat<\/h2>\nTirzepatide is supplied as a lyophilised research material in a sealed vial.<\/p>\n Lyophilisation removes moisture from the material and is commonly used to support stability during controlled storage and transportation. The physical appearance of the product may vary slightly depending on quantity, production conditions and residual moisture.<\/p>\n Product identity and quality should be assessed using the applicable batch information rather than physical appearance alone.<\/p>\n Qualit\u00e4t und Transparenz<\/h2>\nPeptides Divas focuses on clear product information, batch-level traceability and professional presentation.<\/p>\n Depending on the applicable batch, product documentation may contain:<\/p>\n
|